bioRxivCancer BiologyPreprint
Modeling vaccine-induced immunotherapy: treatment scheduling and robustness with virtual mice cohorts
P. Bhatt, M. Kambara, S. Pilon-Thomas, K. A. Rejniak, I. M. Chamseddine
Abstract
Therapeutic vaccines are used to boost patients immune system activity by imposing signals that increase T cell proliferation or infiltration. A large population of cytotoxic T cells may then be able to reduce tumor growth. We developed here a mathematical model of vaccine-induced immunotherapy and used it to test the vaccine frequency and doses that can reduce tumor burden. Since tumors are heterogeneous, we examined if the proposed treatments are robust; i.e, are successful for a wide range of tumors. This was assessed by constructing virtual mice cohorts. Together, the optimal and most robust treatment protocol was determined through mathematical modeling.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- From concept to clinic: mathematically informed immunotherapy
Rachel Walker, Heiko Enderling·Current Problems in CancerPeer-reviewed·Jan 1, 2016
- Optimizing the Efficacy of Vaccine-Induced Immunotherapy in Melanomas
Ibrahim M. Chamseddine, Manoj Kambara, … Katarzyna Anna Rejniak·Bulletin of Mathematical BiologyPeer-reviewed·May 28, 2025
- Addressing current challenges in cancer immunotherapy with mathematical and computational modeling
Anna Konstorum, Anthony T. Vella, … Reinhard Laubenbacher·Journal of The Royal Society InterfacePeer-reviewed·Jun 1, 2017
- Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapy
J. O. Aponte-Serrano, A. Hagar·bioRxiv·Sep 4, 2020
- A minimal model of T cell avidity may identify subtherapeutic vaccine schedules
A. Kumbhari, D. Rose, … P. S. Kim·bioRxiv·Dec 6, 2020
- The Goldilocks Window of Personalized Chemotherapy: An Immune Perspective
D. S. Park, M. Robertson-Tessi, … A. R. Anderson·bioRxiv·Dec 13, 2018